ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479

Watchlist Manager
ZhuZhou QianJin Pharmaceutical Co Ltd Logo
ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479
Watchlist
Price: 10.24 CNY -0.49%
Market Cap: 5B CNY

Relative Value

The Relative Value of one ZhuZhou QianJin Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 10.24 CNY, ZhuZhou QianJin Pharmaceutical Co Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ZhuZhou QianJin Pharmaceutical Co Ltd Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
39
vs Industry
67
Median 3Y
1.4
Median 5Y
1.4
Industry
2.6
vs History
22
vs Industry
30
Median 3Y
18.2
Median 5Y
16.9
Industry
21.4
vs History
71
vs Industry
36
Median 3Y
11.6
Median 5Y
10.6
Industry
16.4
vs History
74
vs Industry
27
Median 3Y
12.8
Median 5Y
12.5
Industry
22.8
vs History
73
vs Industry
41
Median 3Y
2.2
Median 5Y
2.2
Industry
2.2
vs History
4
vs Industry
76
Median 3Y
1.1
Median 5Y
1.1
Industry
2.9
vs History
11
vs Industry
73
Median 3Y
2.5
Median 5Y
2.4
Industry
5.5
vs History
6
vs Industry
38
Median 3Y
10.7
Median 5Y
10.2
Industry
13
vs History
6
vs Industry
41
Median 3Y
10.7
Median 5Y
10.2
Industry
16.5
vs History
49
vs Industry
44
Median 3Y
9
Median 5Y
8.6
Industry
15.6
vs History
44
vs Industry
34
Median 3Y
10
Median 5Y
9.5
Industry
18.7
vs History
88
vs Industry
50
Median 3Y
1.6
Median 5Y
1.6
Industry
1.9

Multiples Across Competitors

Competitors Multiples
ZhuZhou QianJin Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479
5B CNY 1.4 20.2 16.7 16.7
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.6 56.9 38.1 40.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
499.3B USD 5.4 19.9 16.3 21.1
CH
Roche Holding AG
SIX:ROG
269.3B CHF 4.4 28.6 12.2 14.2
UK
AstraZeneca PLC
LSE:AZN
220.6B GBP 5.1 31.6 108.8 159.2
US
Merck & Co Inc
NYSE:MRK
270.1B USD 4.2 14.2 10.1 11.9
CH
Novartis AG
SIX:NOVN
218B CHF 4.9 19 12 15.5
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.2 15.7 10.9 12.7
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.7B USD 2.3 14.6 7.5 10.2
P/E Multiple
Earnings Growth PEG
CN
ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479
Average P/E: 24.5
20.2
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
56.9
54%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
28.6
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.6
37%
0.9
US
Merck & Co Inc
NYSE:MRK
14.2
15%
0.9
CH
Novartis AG
SIX:NOVN
19
17%
1.1
DK
Novo Nordisk A/S
CSE:NOVO B
15.7
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479
Average EV/EBITDA: 401.6
16.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.1
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.3
9%
1.8
CH
Roche Holding AG
SIX:ROG
12.2
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.8
10%
10.9
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
CH
Novartis AG
SIX:NOVN
12
6%
2
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
1%
10.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
ZhuZhou QianJin Pharmaceutical Co Ltd
SSE:600479
Average EV/EBIT: 1 714
16.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
40.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
14.2
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
159.2
23%
6.9
US
Merck & Co Inc
NYSE:MRK
11.9
8%
1.5
CH
Novartis AG
SIX:NOVN
15.5
12%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
12.7
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5